121 related articles for article (PubMed ID: 2464099)
1. Atrial natriuretic peptide administered as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites.
Petrillo A; Scherrer U; Gonvers JJ; Nussberger J; Marder H; de Vane P; Waeber B; Hofstetter JR; Brunner HR
J Cardiovasc Pharmacol; 1988 Sep; 12(3):279-85. PubMed ID: 2464099
[TBL] [Abstract][Full Text] [Related]
2. Human atrial natriuretic peptide (ANP) for the treatment of patients with liver cirrhosis and ascites.
Brabant G; Jüppner H; Kirschner M; Böker K; Schmidt FW; Hesch RD
Klin Wochenschr; 1986; 64 Suppl 6():108-11. PubMed ID: 2948056
[TBL] [Abstract][Full Text] [Related]
3. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
Franco-Saenz R; Somani P; Mulrow PJ
Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner HR
Fundam Clin Pharmacol; 1988; 2(5):413-29. PubMed ID: 2976727
[TBL] [Abstract][Full Text] [Related]
6. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
[TBL] [Abstract][Full Text] [Related]
7. Infusion of atrial natriuretic peptide to patients with congestive heart failure.
Goy JJ; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner HR
J Cardiovasc Pharmacol; 1988; 12(5):562-70. PubMed ID: 2468056
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites.
Laffi G; Marra F; Pinzani M; Meacci E; Tosti-Guerra C; De Feo ML; Gentilini P
Liver; 1989 Dec; 9(6):315-21. PubMed ID: 2532698
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
10. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
[TBL] [Abstract][Full Text] [Related]
11. Bolus injections of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome.
Burnier M; Mooser V; Wauters JP; Marder HK; De Vane P; Nussberger J; Waeber B; Brunner HR
J Cardiovasc Pharmacol; 1989 May; 13(5):682-90. PubMed ID: 2472515
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites.
Laffi G; Pinzani M; Meacci E; La Villa G; Renzi D; Baldi E; Cominelli F; Marra F; Gentilini P
Gastroenterology; 1989 Jan; 96(1):167-77. PubMed ID: 2535828
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide infusion in primary aldosteronism. Renal, hemodynamic and hormonal effects.
Rocco S; Opocher G; Carpenè G; Mantero F
Am J Hypertens; 1990 Sep; 3(9):668-73. PubMed ID: 2145872
[TBL] [Abstract][Full Text] [Related]
14. Renal and hemodynamic effects of atrial natriuretic peptide in patients with cirrhosis.
Fried T; Aronoff GR; Benabe JE; Brunner HR; DiBona GF; Fleischhauer T; Lam M; Lawton WJ; Luft FC; Martinez-Maldonado M
Am J Med Sci; 1990 Jan; 299(1):2-9. PubMed ID: 2136974
[TBL] [Abstract][Full Text] [Related]
15. Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia.
Koda M; Sakamoto A; Ogawa R
J Clin Anesth; 2005 Feb; 17(1):3-7. PubMed ID: 15721722
[TBL] [Abstract][Full Text] [Related]
16. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
17. Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion.
Legault L; Warner LC; Leung WM; Logan AG; Blendis LM; Skorecki KL
Can J Physiol Pharmacol; 1993 Feb; 71(2):157-64. PubMed ID: 8319139
[TBL] [Abstract][Full Text] [Related]
18. Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?
Singer DR; Markandu ND; Buckley MG; Miller MA; Sugden AL; Sagnella GA; MacGregor GA
Clin Sci (Lond); 1989 Sep; 77(3):253-8. PubMed ID: 2530019
[TBL] [Abstract][Full Text] [Related]
19. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion.
Badalamenti S; Borroni G; Lorenzano E; Incerti P; Salerno F
Hepatology; 1992 May; 15(5):824-9. PubMed ID: 1533201
[TBL] [Abstract][Full Text] [Related]
20. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis.
Gantzel RH; Kjær MB; Jepsen P; Aagaard NK; Watson H; Gluud LL; Grønbæk H
World J Hepatol; 2022 Apr; 14(4):827-845. PubMed ID: 35646272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
